Picumast dihydrochloride | CAS# 39577-20-3 | anti-allergic

MedKoo Cat#: 412139 | Name: Picumast dihydrochloride

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Picumast dihydrochloride is a prophylactically active anti-allergic compound which combines inhibition of mediator release and action. The activity profile of PDH differs clearly from that of known prophylactic anti-allergic drugs such as DSCG and ketotifen.

Chemical Structure

Picumast dihydrochloride

CAS#39577-20-3 (HCl)

Theoretical Analysis

MedKoo Cat#: 412139

Name: Picumast dihydrochloride

CAS#: 39577-20-3 (HCl)

Chemical Formula: C25H31Cl3N2O3

Exact Mass: 0.0000

Molecular Weight: 513.88

Elemental Analysis: Chemical Formula: Exact Mass: Molecular Weight: Elemental Analysis: C, 58.43; H, 6.08; Cl, 20.70; N, 5.45; O, 9.34

Price and Availability

Size	Price	Availability	Quantity

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

39577-20-3 (HCl) 39577-19-0 (free base)

Synonym

Picumast dihydrochloride; BM-15100; BM15100; BM 15100 ; BM-15,100; BM15,100; BM 15,100

IUPAC/Chemical Name

2H-1-Benzopyran-2-one, 7-(3-(4-((4-chlorophenyl)methyl)-1-piperazinyl)propoxy)-3,4-dimethyl-, dihydrochloride

InChi Key

AMHVERUFVROLJA-UHFFFAOYSA-N

InChi Code

InChI=1S/C25H29ClN2O3.2ClH/c1-18-19(2)25(29)31-24-16-22(8-9-23(18)24)30-15-3-10-27-11-13-28(14-12-27)17-20-4-6-21(26)7-5-20;;/h4-9,16H,3,10-15,17H2,1-2H3;2*1H

SMILES Code

O=C1C(C)=C(C)C2=CC=C(OCCCN3CCN(CC4=CC=C(Cl)C=C4)CC3)C=C2O1.[H]Cl.[H]Cl

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Product Data

Product Data

Instruction

View handling instruction

Biological target:

Picumast dihydrochloride is a prophylactically active anti-allergic compound which combines inhibition of mediator release and action.

In vitro activity:

TBD

In vivo activity:

TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 513.88 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:

TBD

In vitro protocol:

TBD

In vivo protocol:

TBD

1: Wilhelms OH, Roesch A, Schaumann W. Picumast dihydrochloride (Auteral), a new anti-allergic inhibitor of mediator release and action. Agents Actions Suppl. 1991;34:335-49. PMID: 1686528. 2: Hockwin O, Müller-Breitenkamp U, Laser H, Messinger D, Goder G, Meinel U. Lens safety study with Picumast dihydrochloride--a double masked study using the Scheimpflug method. Lens Eye Toxic Res. 1990;7(3-4):625-30. PMID: 1983108. 3: Boerner D, Metz K, Eberhardt R. Acceptability, safety and efficacy of picumast dihydrochloride on long-term use in patients with perennial bronchial asthma. Arzneimittelforschung. 1989 Oct;39(10A):1372-4. PMID: 2576367. 4: Slapke J, Müller S, Boerner D. A one-year double-blind clinical study of the efficacy and tolerability of picumast dihydrochloride versus ketotifen in patients with bronchial asthma. Arzneimittelforschung. 1989 Oct;39(10A):1368-72. PMID: 2576366. 5: Boerner D, Metz K, Eberhardt R. Efficacy and tolerability of picumast dihydrochloride in comparison with placebo in asthmatic patients. Arzneimittelforschung. 1989 Oct;39(10A):1363-7. PMID: 2576365. 6: Franke W, Messinger D. Double-blind multicenter controlled clinical study comparing the efficacy of picumast dihydrochloride versus astemizole and placebo in patients with seasonal allergic rhinitis. Arzneimittelforschung. 1989 Oct;39(10A):1360-3. PMID: 2576364. 7: Boerner D, Metz K, Eberhardt R, Schürmann W. A placebo-controlled comparison of the efficacy and tolerability of picumast dihydrochloride and terfenadine in patients with seasonal allergic rhinitis. Arzneimittelforschung. 1989 Oct;39(10A):1356-9. PMID: 2576363. 8: Franke W, Bachert C, Messinger D. Double-blind controlled crossover study comparing the protective effect of picumast dihydrochloride versus placebo following nasal allergen challenge. Arzneimittelforschung. 1989 Oct;39(10A):1354-6. PMID: 2576362. 9: Herberg KW. Double-blind study on the influence of picumast dihydrochloride on safety-related performance. Arzneimittelforschung. 1989 Oct;39(10A):1348-51. PMID: 2576361. 10: Neugebauer G, Raedsch R, Stiehl A, Kaufmann B, Besenfelder E, Neubert P, Walter-Sack I. Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis. Arzneimittelforschung. 1989 Oct;39(10A):1343-7. PMID: 2576360. 11: Wittenbrink-Dix AM, Neugebauer G, Fuhr U, Neubert P, Besenfelder E, Woelke- Seidl E, Harder S, Staib AH. Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in man. Arzneimittelforschung. 1989 Oct;39(10A):1339-43. PMID: 2576359. 12: Neugebauer G, Wittenbrink-Dix AM, Woelke-Seidl E, Kaufmann B, Ponton T, Dahmen W, Mosberg H, Nieder N, Besenfelder E. Pharmacokinetics of picumast dihydrochloride and its active metabolites M1 and M2 in humans. Arzneimittelforschung. 1989 Oct;39(10A):1336-9. PMID: 2576358. 13: Abraham WM. Effect of picumast dihydrochloride on antigen-induced early and late airway responses in allergic sheep. Arzneimittelforschung. 1989 Oct;39(10A):1328-31. PMID: 2576357. 14: Schaumann W, Besenfelder E, Boehm E, Neubert P, Roesch A, Sterz H. Pharmacokinetics of picumast after administration of 14C-picumast dihydrochloride in dogs, rats, rabbits and monkeys. Arzneimittelforschung. 1989 Oct;39(10A):1321-7. PMID: 2576356. 15: Besenfelder E, Neubert P, Roesch A, Schaumann W, Wilhelms OH. Metabolism of picumast after administration of picumast dihydrochloride and antiallergic activity of the main metabolites. Arzneimittelforschung. 1989 Oct;39(10A):1317-20. PMID: 2576355. 16: Roesch A, Schaumann W, Wilhelms OH. Antiallergic activity of picumast dihydrochloride in several animal species. Arzneimittelforschung. 1989 Oct;39(10A):1310-6. PMID: 2576354. 17: Witte EC. Chemical synthesis of picumast dihydrochloride. Arzneimittelforschung. 1989 Oct;39(10A):1309. PMID: 2576353. 18: Zimmermann I, Roesch A, Ulmer WT. Influence of picumast dihydrochloride on the ex vivo histamine release from leucocytes of allergic asthmatic patients. Arzneimittelforschung. 1989 Oct;39(10A):1351-3. PMID: 2483313. 19: Sekardi L, Friedberg KD. Inhibition of immunological histamine release from guinea pig lungs and other organs by mepyramine, ketotifen, and picumast in vivo. Arzneimittelforschung. 1989 Oct;39(10A):1331-5. PMID: 2483312.